CLINICAL_TRIALS trial_result · 2015-10-05

Clinical Trial Update: Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL) [Phase 2]

Phase 2 trial of sorafenib for chronic lymphocytic leukemia was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Thomas Kipps | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2015-10-05